
Address
Technology Partners.
550 University Avenue
Palo Alto, CA 94301
United States
Phone
Website
Tags
VCID: 28603
Profile
Corporate information
Registration country
Investment activity status
Active investor
Company type
Venture capital firmFunds managed
Fund | Type | Vintage |
---|---|---|
Technology Partners Fund VII LP | ||
Technology Partners Fund VI LP | ||
Technology Partners Fund V LP |
Team
Current employees
![]() |
Jim Glasheen | ||
![]() |
Sheila Mutter |
Investments
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
![]() |
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Jun 2012 | Series D |
|
![]() |
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jan 2010 1 Jun 2011 |
Venture |
|
![]() |
TRIA Beauty Inc |
United States | 1 May 2007 1 Sep 2010 31 Dec 2008 |
Venture |
|
![]() |
Incline Therapeutics Inc Patient controlled analgesia |
United States | 1 Jun 2010 | Series A |
|
![]() |
Visiogen Inc A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. |
United States | 1 May 2009 | Series D Initial investment. Round participant. Active |
|
![]() |
NanoGram Corp Maker of core process technology for the manufacture of nanostructured materials for optical, electronic and energy applications |
United States | 18 Jan 2006 | Venture Led the investment round. Active |
|
![]() |
Encirq Corp |
United States | 1 Dec 2004 | Series A |
|
![]() |
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. |
United States | 31 Dec 2003 | Series C |
|
![]() |
Rinat Neuroscience Corp Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases |
United States | 1 Aug 2003 | Series B Follow-on investment. Round participant. Active |